Ning Liu

Dr. Ning Liu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZMZong Miao
Zong Miao
WTWei Tian
Wei Tian
YYYangfan Ye
Yangfan Ye
WGWei Gu
Wei Gu
ZBZhongyuan Bao
Zhongyuan Bao
JJJi Jing
Ji Jing
Ferroptosis is a newly identified form of regulated cell death (RCD) characterized by the iron-dependent lipid reactive oxygen species (ROS) accumulation, but its mechanism in gliomas remains elusive. Acyl–coenzyme A (CoA) synthetase long-chain family member 4 (Acsl4), a pivotal enzyme in the regulation of lipid biosynthesis, benefits the initiation of ferroptosis, but its role in gliomas needs further clarification. Erastin, a classic inducer of ferroptosis, has recently been found to regulate lipid peroxidation by regulating Acsl4 other than glutathione peroxidase 4 (GPX4) in ferroptosis. In this study, we demonstrated that heat shock protein 90 (Hsp90) and dynamin-related protein 1 (Drp1) actively regulated and stabilized Acsl4 expression in erastin-induced ferroptosis in gliomas. Hsp90 overexpression and calcineurin (CN)–mediated Drp1 dephosphorylation at serine 637 (Ser637) promoted ferroptosis by altering mitochondrial morphology and increasing Acsl4-mediated lipid peroxidation. Importantly, promotion of the Hsp90–Acsl4 pathway augmented anticancer activity of erastin in vitro and in vivo. Our discovery reveals a novel and efficient approach to ferroptosis-mediated glioma therapy.

1 October 2018 in Cancer Letters
Verified
Journal Article
Closed access
TYTianfu Yu
Tianfu Yu
XWXieFeng Wang
XieFeng Wang
TZTongle Zhi
Tongle Zhi
JZJunxia Zhang
Junxia Zhang
YWYingyi Wang
Yingyi Wang
NLNing Liu
Ning Liu

27 September 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TYTianfu Yu
Tianfu Yu
YWYingyi Wang
Yingyi Wang
QHQi Hu
Qi Hu
WWWeiNing Wu
WeiNing Wu
YWYouzhi Wu
Youzhi Wu
NLNing Liu
Ning Liu
The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

21 February 2013 in RNA
Verified
Journal Article
Open access
PDF file
ZSZhu-Mei Shi
Zhu-Mei Shi
XWXie-Feng Wang
Xie-Feng Wang
XQXu Qian
Xu Qian
TTTao Tao
Tao Tao
LWLin Wang
Lin Wang
YYYongping You
Yongping You
MicroRNAs (miRNAs) are single-stranded, 18- to 23-nt RNA molecules that function as regulators of gene expression. Previous studies have shown that microRNAs play important roles in human cancers, including gliomas. Here, we found that expression levels of miR-181b were decreased in gliomas, and we identified IGF-1R as a novel direct target of miR-181b. MiR-181b overexpression inhibited cell proliferation, migration, invasion, and tumorigenesis by targeting IGF-1R and its downstream signaling pathways, PI3K/AKT and MAPK/ERK1/2. Overexpression of IGF-1R rescued the inhibitory effects of miR-181b. In clinical specimens, IGF-1R was overexpressed, and its protein levels were inversely correlated with miR-181b expression. Taken together, our results indicate that miR-181b functions in gliomas to suppress growth by targeting the IGF-1R oncogene and that miR-181b may serve as a novel therapeutic target for gliomas.

3 October 2013 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
XWX.-R. Wang
X.-R. Wang
HLHui Luo
Hui Luo
HLHai-Lin Li
Hai-Lin Li
LCLei Cao
Lei Cao
XWX.-F. Wang
X.-F. Wang
C(Chinese Glioma Cooperative Group (CGCG)
Chinese Glioma Cooperative Group (CGCG)
Altered expression of micro(mi)RNAs has been shown to be associated with tumorigenesis and tumor progression. The expression of phosphatase and tensin homolog (PTEN) plays an important role in glioma and is regarded as a prognostic marker of glioma patients. The goal of this study was to investigate the function of lethal (let)-7a miRNA in glioma cell lines with different PTEN phenotypes. One hundred ninety-eight glioma tissues were used to profile miRNA expression. Let-7a was shown to have lower expression in high-grade glioma than in low-grade glioma. Low expression of let-7a was correlated with poor prognosis of primary glioblastoma patients. We demonstrated that K-ras was a functional target for let-7a to induce cell cycle arrest, apoptosis, and inhibition of cell migration and invasion in vitro. Our further results showed no difference in malignancy inhibition induced by let-7a in 4 glioma cells, including U87 (PTEN null), U251 (PTEN mutant), LN229 (PTEN wild type), and LN229 (PTEN small interfering RNA). The phosphatidylinositol-3 kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase pathways were inhibited by let-7a, and the inhibition effects had no difference in 4 glioma cells. We demonstrated that let-7a could induce suppression of glioma in vivo by generating a glioma xenograft model. Our results indicated that let-7a suppresses its target transcript K-ras and inhibits glioma malignancy independent of PTEN expression.

1 September 2013 in European Journal of Cancer
Verified
Journal Article
Closed access
TTTao Tao
Tao Tao
YWYingyi Wang
Yingyi Wang
HLHui Luo
Hui Luo
LYLei Yao
Lei Yao
LWLin Wang
Lin Wang
YYYongping You
Yongping You